Recommendations from the Spanish Oncology Genitourinary Group for the Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer

This clinical practice guideline reviews treatment options for patients with metastatic castration-resistant prostate cancer. Hormonal therapy, first-line chemotherapy, biological and immunotherapy, bone targeted treatments, radionuclides, and palliative treatments are discussed. Outcomes of interest include median and overall survival, and adverse events.